Funder
D.J.S. is a scientific advisory board member of Xylocor
A.G. was a full-time employee of XyloCor Therapeutics when this work was done.
D.B. was a full-time employee of XyloCor Therapeutics when this work was done.
H.C.D. was a full-time employee of XyloCor Therapeutics when this work was done.
B.T. was a full-time employee of XyloCor Therapeutics when this work was done.
R.R.R. was a full-time employee of XyloCor Therapeutics when this work was done.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference30 articles.
1. Henry TD, Satran D, Hodges JS, Johnson RK, Poulose AK, Campbell AR, et al. Long-term survival in patients with refractory angina. Eur Heart J. 2013;34:2683–8.
2. Cheng K, de Silva R. New advances in the management of refractory angina pectoris. Eur Cardiol. 2018;13:70–9.
3. Krock BL, Skuli N, Celeste Simon M. Hypoxia-Induced Angiogenesis: Good and Evil. Genes Cancer. 2011;2:1117–33.
4. Wold WSM, Ison MG. Adenoviruses. In: Fields BN, Knipe DM and Howley PM (eds). Fields Virology, Vol 1. 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2013. pp 1732–67.
5. Ylä-Herttuala S, Baker AH. Cardiovascular gene therapy: past, present, and future. Mol Ther. 2017;25:1095–106.